David J. Chang - Jan 18, 2022 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
Chief Medical Officer
Signature
By: /s/ Michael Gerard, as Attorney-in-Fact
Stock symbol
CABA
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 06:54 PM
Next filing
Jan 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CABA Stock Option (Right to Buy) Award $0 +135K $0.00 135K Jan 18, 2022 Common Stock 135K $3.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on January 18, 2023, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney